|Articles|October 15, 2016

BioPharm International

  • BioPharm International-10-15-2016
  • Volume 2016 eBook
  • Issue 2

Cell Line Quality Technologies

Author(s)Susan Haigney

BioPharm International spoke with Selexis CEO and Chairman Igor Fisch, PhD about the latest cell-line development advances.

Chinese hamster ovary (CHO) cells are a common and stable option for mammalian expression systems, but what are the other cell line options in upstream processing and how do they compare in quality and stability to CHO cells? And what are the best techniques for ensuring quality and stability in cell-line development?  BioPharm International spoke with Selexis CEO and Chairman Igor Fisch, PhD about the latest cell-line development advances and the analytical techniques companies can use to ensure quality and stability.

 

Download the BioPharm International

Bioprocessing Trends 2016 eBook

.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.